ATS 2018 International Conference - Mobile

John Ryan

MD PhD

Kadmon Corporation, LLC

Session(s)

A Phase 2 Trial of KD025 to Assess Efficacy, Safety and Tolerability in Patients with Idio...
Tuesday, May 22 3:30 PM - 3:45 PM